Skip to main content

and
  1. Article

    Open Access

    Assessing suitability for long-term colorectal cancer shared care: a scenario-based qualitative study

    Shared care is the preferred model for long-term survivorship care by cancer survivors, general practitioners and specialists. However, survivorship care remains specialist-led. A risk-stratified approach has ...

    Kylie Vuong, Kerry Uebel, Maria Agaliotis, Stella Jun, Jane Taggart in BMC Family Practice (2020)

  2. Article

    Open Access

    Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial

    Planar-based measurements of lesions in metastatic melanoma have limitations in estimating tumor burden of a patient and in predicting response to treatment. Volumetric imaging might add predictive value to Re...

    Arwa Ali, Monica Dumbrava, Kylie Riddell, Nina Stewart, Robyn Ward in BMC Cancer (2020)

  3. Article

    Open Access

    Using behaviour change and implementation science to address low referral rates in oncology

    Patients undergoing surgery for bowel cancer now have a routine screening test to assess their genetic predisposition to this and other cancers (Lynch syndrome). A result indicating a high risk should trigger ...

    Janet C. Long, Deborah Debono, Rachel Williams in BMC Health Services Research (2018)

  4. Article

    Open Access

    Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: a case report

    Follicular dendritic cell sarcoma is a rare tumour with clinical behaviour covering a spectrum from indolent to aggressive disease. Treatment recommendations are currently based on case reports and small serie...

    Charlotte R. Lemech, Rachel Williams, Stephen R. Thompson in BMC Research Notes (2016)

  5. Article

    Open Access

    Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer

    To investigate the factors that affect the choice of 5-fluorouracil (5-FU) or its oral alternative, capecitabine, as first-line treatment in patients with colorectal cancer (CRC).

    Lourens T. Bloem, Richard De Abreu Lourenço, Melvin Chin, Brett Ly in Oncology and Therapy (2016)

  6. Article

    Open Access

    Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: a study protocol

    Lynch syndrome is an inherited disorder associated with a range of cancers, and found in 2–5 % of colorectal cancers. Lynch syndrome is diagnosed through a combination of significant family and clinical histor...

    Natalie Taylor, Janet C. Long, Deborah Debono in BMC Health Services Research (2016)

  7. Article

    Open Access

    Cutaneous metastasis of prostate carcinoma treated with radiotherapy: a case presentation

    Prostate cancer is a commonly diagnosed and treated malignancy, although it rarely presents with cutaneous metastases. In this case presentation, we describe the diagnosis and treatment with radiotherapy of a ...

    Gabriel Mak, Melvin Chin, Najmun Nahar, Paul De Souza in BMC Research Notes (2014)

  8. No Access

    Article

    Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer

    Albendazole is a potential anticancer agent that is currently under development for the treatment of cancer. We carried out a dose-finding phase I study of oral albendazole in patients with advanced malignancies.

    Mohammad H. Pourgholami, Michael Szwajcer in Cancer Chemotherapy and Pharmacology (2010)